EDAP Announces Withdrawal of 510(k) Application for Focal One® to be Followed by New Submission to Conform to FDA Review Rules
July 17, 2017 16:45 ET
|
EDAP TMS SA
New 510(k) With New Clinical Data to be Submitted for Focal One® Initial 510(k) to be submitted for Ablatherm Fusion® LYON, France, July 17, 2017 (GLOBE NEWSWIRE) -- EDAP TMS SA...
EDAP TMS SA Reports First Quarter 2017 Results
May 17, 2017 16:00 ET
|
EDAP TMS SA
Total revenue of EUR 8.7 million (USD 9.3 million) for Q1 2017 +16.5% growth in HIFU treatment driven recurring revenues Strong cash position of EUR 20.3 million (USD 21.7 million) as of March...
EDAP Announces Ablatherm Fusion World Premiere during American Urology Association Annual Meeting in Boston, MA, May 12-16, 2017
May 11, 2017 07:30 ET
|
EDAP TMS SA
EDAP Announces Ablatherm Fusion World Premiere during American Urology Association Annual Meeting in Boston, MA, May 12-16, 2017 EDAP to Showcase Ablatherm Fusion and Sonolith i-move at AUA Booth...
EDAP TMS SA to Report First Quarter 2017 Financial Results on May 17, 2017
May 02, 2017 14:15 ET
|
EDAP TMS SA
LYON, France, May 2, 2017 - EDAP TMS SA (NASDAQ: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the first quarter ended March 31,...
EDAP Achieves 63% Growth in HIFU Revenue in 2016
April 03, 2017 16:01 ET
|
EDAP TMS SA
2016 Highlights Total revenue for 2016 reached double-digit growth, increasing to EUR 35.6 million (USD 39.3 million) Gross margin for 2016 expanded to 46.1% compared to 42.8% during the prior...
EDAP's Ablatherm® Robotic HIFU: Clinical Results Support High-Intensity Focused Ultrasound (HIFU) for Prostate Tissue Ablation after Unsuccessful Radiotherapy
March 22, 2017 07:30 ET
|
EDAP TMS SA
Multicenter Retrospective Analysis of 418 Patients LYON, France, March 22, 2017 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced the publication of a...
EDAP TMS SA to Report Fourth Quarter and Full Year 2016 Results on April 3, 2017
March 14, 2017 07:30 ET
|
EDAP TMS SA
EDAP TMS SA to Report Fourth Quarter and Full Year 2016 Results on April 3, 2017 LYON, France, March 14, 2017 - EDAP TMS SA (NASDAQ: EDAP), the global leader in therapeutic ultrasound, today...
EDAP's Long Term Academic HIFU Partner INSERM LabTAU Designated Center of Excellence by the Focused Ultrasound Foundation
March 08, 2017 10:51 ET
|
EDAP TMS SA
LYON, France, March 8, 2017 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that the prestigious Focused Ultrasound Foundation, based in Charlottesville,...
EDAP Appoints Vice-President of Global Medical, Regulatory and Quality Affairs in the U.S.
March 06, 2017 08:30 ET
|
EDAP TMS SA
EDAP Appoints Vice-President of Global Medical, Regulatory and Quality Affairs in the U.S. LYON, France, March 6, 2017 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound,...
EDAP's Ablatherm® Robotic HIFU Treatments Performed at University of Minnesota
February 27, 2017 07:30 ET
|
EDAP TMS SA
EDAP's Ablatherm® Robotic HIFU Treatments Performed at University of Minnesota LYON, France, February 27, 2017 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today...